Iron supplementation reduces re-hospitalization for heart failure

Nature Reviews Cardiology, Published online: 01 December 2020; doi:10.1038/s41569-020-00490-4In the AFFIRM-AHF trial, the use of intravenous ferric carboxymaltose in patients with acute heart failure and iron deficiency was associated with a reduction in hospitalization for heart failure and cardiovascular death.
Source: Nature Reviews Cardiology - Category: Cardiology Authors: Source Type: research